China Resources Sanjiu Medical & Pharmaceutical Co Ltd SZSE:000999:
PRELIM 2025 NET PROFIT UP 1.6%
China Resources Sanjiu Medical & Pharmaceutical Prelim 2025 Net Profit Up 1.6%
Earlier from China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Class A
- China Resources Sanjiu Medical & Pharmaceutical Co: Revenue surged but profit declined as acquisition and investment costs rose sharply
- China Resources Sanjiu Medical & Pharmaceutical Q3 Net Profit Down 4.3% Y/Y
- China Resources Sanjiu Medical & Pharma To Invest In Wealth Management Products
- China Resources Sanjiu Medical & Pharmaceutical Co: Revenue up 4.99% but net profit down 24.31% as Tasly acquisition reshapes business